Glaxo’s Garnier Rebuts Schering Prediction On Flonase Switch
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline CEO Jean-Pierre Garnier called premature a prediction by Schering-Plough CEO Fred Hassan that FDA could approve a nasal-inhaled steroid for over-the-counter use this year